Literature DB >> 26948447

Bariatric surgery reduces urinary albumin excretion in diabetic nephropathy: a systematic review and meta-analysis.

Sikarin Upala1, Karn Wijarnpreecha2, Soontharee Congrete3, Pattara Rattanawong4, Anawin Sanguankeo5.   

Abstract

BACKGROUND: Bariatric surgery is found to prevent type 2 diabetes, improve glycemic control, and decrease long-term incidence of microvascular and macrovascular complications in obese persons. However, its effect on urinary albumin excretion (UAE) in patients with diabetic nephropathy (DN) is still unknown. This is a systematic review and meta-analysis of observational studies on bariatric surgery and change in UAE in patients with diabetes.
OBJECTIVE: To explore whether there is improvement in UAE after bariatric surgery.
METHODS: We comprehensively searched the databases of MEDLINE, Embase, and Cochrane. The inclusion criteria were published studies evaluating effects of bariatric surgery in patients with DN at baseline. The primary outcome was the pre- and postbariatric surgery UAE as characterized by urinary albumin-to-creatinine ratio and albuminuria. A meta-analysis comparing pre- and postsurgery UAE was performed.
RESULTS: From 65 full-text articles, 15 observational studies met our inclusion criteria, and 11 studies were included in the meta-analysis based on the random effects model. There was a significant reduction in urinary albumin-to-creatinine ratio after bariatric surgery with a mean difference of -6.60 mg/g of creatinine (95% CI -9.19 to -4.02; P<.001). There was also a reduction in albuminuria with a mean difference of -55.76 mg/24 hours (95% CI -92.11 to -19.41; P<.001) after bariatric surgery.
CONCLUSION: Bariatric surgery significantly decreases urinary albumin excretion in DN. However, studies comparing bariatric surgery and conventional or intensive care of diabetes on UAE outcome should be done.
Copyright © 2016 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Diabetic nephropathy; Microvascular complication; Proteinuria; Urinary albumin excretion

Mesh:

Year:  2015        PMID: 26948447     DOI: 10.1016/j.soard.2015.11.019

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  10 in total

1.  Improvement of Renal Function After Bariatric Surgery: a Systematic Review and Meta-analysis.

Authors:  Hongyan Huang; Jun Lu; Xiaojiang Dai; Zhixin Li; Liyong Zhu; Shaihong Zhu; Liangping Wu
Journal:  Obes Surg       Date:  2021-08-06       Impact factor: 4.129

2.  Downregulation of lncRNA MALAT1 contributes to renal functional improvement after duodenal-jejunal bypass in a diabetic rat model.

Authors:  Dong Wu; Yu-Gang Cheng; Xin Huang; Ming-Wei Zhong; Shao-Zhuang Liu; San-Yuan Hu
Journal:  J Physiol Biochem       Date:  2018-05-21       Impact factor: 4.158

Review 3.  Bariatric Surgery for Adolescents with Type 2 Diabetes: an Emerging Therapeutic Strategy.

Authors:  M A Stefater; T H Inge
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

4.  Long-term impact of bariatric surgery in diabetic nephropathy.

Authors:  LeAnne Young; Zubaidah Nor Hanipah; Stacy A Brethauer; Philip R Schauer; Ali Aminian
Journal:  Surg Endosc       Date:  2018-09-24       Impact factor: 4.584

5.  Microvascular Outcomes after Metabolic Surgery (MOMS) in patients with type 2 diabetes mellitus and class I obesity: rationale and design for a randomised controlled trial.

Authors:  Ricardo Vitor Cohen; Tiago Veiga Pereira; Cristina Mamédio Aboud; Pedro Paulo de Paris Caravatto; Tarissa Beatrice Zanata Petry; José Luis Lopes Correa; Carlos Aurélio Schiavon; Mariangela Correa; Carlos Eduardo Pompílio; Fernando Nogueira Quirino Pechy; Carel W le Roux
Journal:  BMJ Open       Date:  2017-01-11       Impact factor: 2.692

6.  Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity.

Authors:  Akira Sasaki; Koutaro Yokote; Takeshi Naitoh; Junji Fujikura; Karin Hayashi; Yushi Hirota; Nobuya Inagaki; Yasushi Ishigaki; Kazunori Kasama; Eri Kikkawa; Hidenori Koyama; Hiroaki Masuzaki; Takeshi Miyatsuka; Takehiro Nozaki; Wataru Ogawa; Masayuki Ohta; Shinichi Okazumi; Michio Shimabukuro; Iichiro Shimomura; Hitoshi Nishizawa; Atsuhito Saiki; Yosuke Seki; Nobuhiro Shojima; Motoyoshi Tsujino; Satoshi Ugi; Hiroaki Watada; Toshimasa Yamauchi; Takashi Yamaguchi; Kohjiro Ueki; Takashi Kadowaki; Ichiro Tatsuno
Journal:  Diabetol Int       Date:  2021-11-08

7.  Exploring Renal Changes after Bariatric Surgery in Patients with Severe Obesity.

Authors:  Anna Oliveras; Susana Vázquez; María José Soler; Isabel Galceran; Xavier Duran; Albert Goday; David Benaiges; Marta Crespo; Julio Pascual; Marta Riera
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

8.  Impact of Weight Loss on the Severity of Albuminuria in Obese Diabetic Patients Undergoing Laparoscopic Sleeve Gastrectomy and One-Anastomosis Gastric Bypass.

Authors:  Ahmed Abdallah Salman; Mohamed Abdalla Salman; Mohamed H Aon; Reem Ezzat Mahdy; Ahmed Abdallah; Gamal Galal Shemy; Ahmed M Hassan; Fatema Alzahraa Samy Amin; Safa Labib
Journal:  Int J Gen Med       Date:  2022-08-04

9.  Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease.

Authors:  Meera Nair; William P Martin; Vadim Zhernovkov; Jessie A Elliott; Naomi Fearon; Hans Eckhardt; Janet McCormack; Catherine Godson; Eoin Patrick Brennan; Lars Fandriks; Neil G Docherty; Carel W le Roux
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

10.  Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort Study.

Authors:  Safwaan Adam; Shazli Azmi; Jan H Ho; Yifen Liu; Maryam Ferdousi; Tarza Siahmansur; Alise Kalteniece; Andrew Marshall; Shaishav S Dhage; Zohaib Iqbal; Yvonne D'Souza; Salim Natha; Philip A Kalra; Rachelle Donn; Basil J Ammori; Akheel A Syed; Paul N Durrington; Rayaz A Malik; Handrean Soran
Journal:  Obes Surg       Date:  2020-10-26       Impact factor: 3.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.